NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) announced today that its wholly owned subsidiary, Enzo Life Sciences, Inc., has signed a letter of intent to acquire 10 P’s BVBA, a privately owned distributor of life science research products, with offices in Belgium serving the Benelux countries. Upon completion of the acquisition, which is subject to definitive agreements, Enzo will have local, directly owned presence from which to market its growing line of life sciences reagents and systems. The acquisition is expected to close in February 2008.
